Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives
Multidisciplinary Respiratory Medicine · 13.06.2024 · 19 (Vol. 19 (2024))
DOI: 10.5826/mrm.2024.982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Multidisciplinary Respiratory Medicine, erschienen am 13.06.2024. Verfasst von Carlo Vancheri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Experimental Medicine, "Regional Referral Center for Rare Lung Diseases", University - Hospital Policlinico "G. Rodolico- …. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Idiopathic pulmonary fibrosis (IPF) represents a fibrotic interstitial lung disease characterized by uncertain etiology and poor prognosis. Over the years, the path to effective treatments has been marked by a series of advances and setbacks. The introduction of approved antifibrotic drugs, pirfenidone and nintedanib, marked a pivotal moment in the management of IPF. However, despite these advances, these drugs are not curative, although they can slow the natural progression of the disease. The history of drug therapy for IPF goes together with the increased understanding of the pathogenic mechanisms underlying the disease. Based on that, current research efforts continue to explore new therapies, possible personalized treatment strategies, drug combinations, and potential biomarkers for diagnosis and prognosis. In this review, we outline the route that led to the discover of the first effective therapies, ongoing clinical trials, and future directions in the search for more effective treatments.
Autor:innen und Institutionen
- Department of Clinical and Experimental Medicine, "Regional Referral Center for Rare Lung Diseases", University - Hospital Policlinico "G. Rodolico- San Marco", University of Catania, Catania, 95123 Catania, Italy.
- Internal Medicine Unit, Department of Clinical and Experimental Medicine, Division of Rheumatology, Cannizzaro Hospital, University of Catania, 95123 Catania, Italy.
- Department of Medical Surgical Sciences and Advanced Technologies "GF Ingrassia", University -Hospital Policlinico "G. Rodolico-San Marco", Unità Operativa Semplice Dipartimentale di Imaging Polmonare e Tecniche Radiolo…
Zitieren
APA
Vancheri, C., Sciacca, E., Muscato, G., Spicuzza, L., Fruciano, M., Gili, E., Sambataro, G., Palmucci, S., & Libra, A. (2024). Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives. Multidisciplinary Respiratory Medicine, 19(Vol. 19 (2024)). https://doi.org/10.5826/mrm.2024.982
Vancouver
Vancheri C, Sciacca E, Muscato G, Spicuzza L, Fruciano M, Gili E, et al. Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives. Multidisciplinary Respiratory Medicine. 2024;19(Vol. 19 (2024)). doi:10.5826/mrm.2024.982
BibTeX
@article{Vancheri2024,
author = {Vancheri, Carlo and Sciacca, Enrico and Muscato, Giuseppe and Spicuzza, Lucia and Fruciano, Mary and Gili, Elisa and Sambataro, Gianluca and Palmucci, Stefano and Libra, Alessandro},
title = {Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives},
journal = {Multidisciplinary Respiratory Medicine},
year = {2024},
volume = {19},
number = {Vol. 19 (2024)},
doi = {10.5826/mrm.2024.982}
}
EUVIMED